Medtronic Q3 revenue up 8.7% year-on-year, full-year adjusted EPS guidance below expectations

Glonghui, February 17th｜Medical device manufacturer Medtronic announced its fiscal year 2026 third quarter results, with revenue increasing by 8.7% year-on-year to $9.0 billion, exceeding market expectations by $110 million; adjusted earnings per share were $1.36, surpassing market expectations by $0.02. The company reaffirmed its fiscal year 2026 organic revenue growth forecast of approximately 5.5%, and its adjusted earnings per share forecast of $5.62 to $5.66, which is below the market consensus of $6.12.